Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

769
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influences of smoking behaviors on human immune signatures: large observational studies and Mendelian randomization analyses.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Betulin Protects Against Cardiac Hypertrophy by Improving AMPK/Nrf2-Dependent Mitochondrial Function.

Phytotherapy research : PTR·2026
Same author

EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCT.

British journal of haematology·2025
Same author

Disseminated organ and tissue infection secondary to carbapenem-resistant Klebsiella pneumoniae bloodstream infection for acute lymphoblastic leukemia treated with ceftazidime-avibactam: Two case reports.

Medicine·2025
Same author

Evolution of ceftazidime-avibactam resistance driven by mutations in double-copy <i>bla</i><sub>KPC-2</sub> to <i>bla</i><sub>KPC-189</sub> during treatment of ST11 carbapenem-resistant <i>Klebsiella pneumoniae</i>.

mSystems·2024
Same author

Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series.

Infection and drug resistance·2023

Related Experiment Video

Updated: May 6, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.4K

Optimizing Clinical Indicators in Hematologic Malignancies and Sepsis Using ddPCR: A Retrospective Study.

Bei Zheng1,2,3, Chuanwei Xin1,2,3, Yizhuo Liu4

  • 1Department of Pharmacy, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (Tongde Hospital of Zhejiang Province), Hangzhou, 310012, Zhejiang, China.

Infectious Diseases and Therapy
|August 29, 2025
PubMed
Summary

Droplet digital PCR (ddPCR) significantly improves sepsis diagnosis in hematologic malignancy patients, offering faster results and better outcomes. This rapid detection aids in optimizing antibacterial treatment and reducing mortality.

Keywords:
28-day all-cause mortalityAntimicrobial stewardshipHematologic malignanciesSepsisddPCR

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K
Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

5.3K

Related Experiment Videos

Last Updated: May 6, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K
Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

5.3K

Area of Science:

  • Infectious Diseases
  • Molecular Diagnostics
  • Hematology

Background:

  • Early antibacterial treatment is crucial for hematologic malignancy (HM) patients with sepsis.
  • Droplet digital PCR (ddPCR) offers rapid pathogen and antimicrobial resistance (AMR) gene detection.
  • The clinical utility of ddPCR in HM patients with sepsis remains under investigation.

Purpose of the Study:

  • To systematically evaluate the role of ddPCR in the diagnosis of sepsis in HM patients.
  • To assess the impact of ddPCR on clinical outcomes and antimicrobial stewardship.
  • To compare ddPCR performance against traditional blood cultures (BC).

Main Methods:

  • A study involving 400 HM patients with sepsis from January 2023 to March 2025.
  • Comparison of ddPCR combined with BC (150 patients) versus BC alone (250 patients).
  • Propensity score matching (PSM), subgroup, and sensitivity analyses were employed to evaluate outcomes including 28-day mortality and antibiotic use density (AUD).

Main Results:

  • ddPCR demonstrated a higher positive rate (49.33% vs. 17.50%) and significantly faster turnaround time (4.06h vs. 72.47h) compared to BC.
  • The ddPCR group showed reduced 28-day mortality (HR=0.55), improved clinical response rates, and greater inflammatory marker decline.
  • Antimicrobial optimization guided by ddPCR led to improved efficacy (85.11%) and reduced AUD (OR=-28.93).

Conclusions:

  • ddPCR significantly outperforms BC in diagnostic efficiency for HM patients with sepsis.
  • ddPCR accelerates pathogen and AMR gene identification, leading to optimized antibacterial therapy and improved clinical outcomes.
  • The study supports the implementation of ddPCR for managing sepsis in immunosuppressed populations.